Prescription Drug Pricing
EBLF
Headed for Catastrophe
Multimillion-dollar health claims are on the rise due in part to specialty drugs...
May 31, 2022
EBLF
Taking on Big Pharma
Q&A with Dr. Alex Oshmyansky, Founder and CEO, and Ron Harrison, VP, Business De...
April 1, 2022
Health+Benefits
Next Generation Medicine: Specialty Drug Costs, Data & Supply Chain
The latest specialty drug cost management levers that employers and plan sponsor...
September 15, 2021
Health+Benefits
Managing Medical Stop Loss
Stop loss carriers’ creativity is being tested in helping employers navigate h...
June 1, 2021
Health+Benefits
Do Bipartisan Healthcare Cost Solutions Exist?
A D.C. insider’s perspective on the chances of major drug pricing and ACA refo...
February 2, 2021
Health+Benefits
David Axelrod
On the future of the ACA, prescription drugs, pollsters, and whether Mitch McCon...
January 20, 2021
Health+Benefits
The Compounding Business
Q&A with Tara Thompson, Pharmacist and Vice President of Clinical Services at In...
January 19, 2021
Health+Benefits
Compounding Cost Savings
Q&A with Dhaval Bhanusali, MD, Dermatologist and Founder of Skin Medicinals
January 19, 2021
Podcasts
On the Mic with David Axelrod
The Council's Joel Wood follows up with political analyst David Axelrod for an e...
December 14, 2020
Health+Benefits
Runaway Freight Train
Transparency alone isn’t enough to lower drug costs, but it’s a critical ste...
November 13, 2020
